Skip to main content
Erschienen in: Advances in Therapy 2/2019

08.01.2019 | Correction

Correction to: Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension

verfasst von: Katsuyoshi Suzuki, Naomi Otsuka, Hiroko Hizaki, Masayo Hashimoto, Yasuaki Kuwayama, On behalf of the Tafluprost/Timolol Versus Latanoprost/Timolol (TTVLT) Study Group

Erschienen in: Advances in Therapy | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

In the original publication, the range to derive the P values is incorrectly represented in Tables 2 and 3. The corrected tables are provided below.
Table 2
Mean (± standard deviation) superficial punctate keratopathy scores (range 0–3)
https://static-content.springer.com/image/art%3A10.1007%2Fs12325-018-0864-0/MediaObjects/12325_2018_864_Tab2_HTML.png
Bold indicates significant values
BL baseline, LAT latanoprost, SPK superficial punctate keratopathy, TAF tafluprost, TIM timolol
aData missing for one patient in the LAT/TIM group
bCalculated using Wilcoxon two-sample test
cCalculated using Wilcoxon one-sample test
Table 3
Mean (± standard deviation) tear break-up times and hyperemia scores (range 0–3)
https://static-content.springer.com/image/art%3A10.1007%2Fs12325-018-0864-0/MediaObjects/12325_2018_864_Tab3_HTML.png
BL baseline, LAT latanoprost, TAF tafluprost, TBUT tear breakup time, TIM timolol
aData missing for one patient in the LAT/TIM group
bCalculated using t test
cCalculated using Wilcoxon two-sample test
dCalculated using Wilcoxon one-sample test
Metadaten
Titel
Correction to: Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
verfasst von
Katsuyoshi Suzuki
Naomi Otsuka
Hiroko Hizaki
Masayo Hashimoto
Yasuaki Kuwayama
On behalf of the Tafluprost/Timolol Versus Latanoprost/Timolol (TTVLT) Study Group
Publikationsdatum
08.01.2019
Verlag
Springer Healthcare
Erschienen in
Advances in Therapy / Ausgabe 2/2019
Print ISSN: 0741-238X
Elektronische ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-018-0864-0

Weitere Artikel der Ausgabe 2/2019

Advances in Therapy 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.